H. Ida et al., TYPE-1 GAUCHER-DISEASE - PHENOTYPIC-EXPRESSION AND NATURAL-HISTORY INJAPANESE PATIENTS, Blood cells, molecules, & diseases, 24(5), 1998, pp. 73-81
Gaucher disease is caused by a deficiency of glucocerebrosidase, resul
ting in hepatosplenomegaly, pancytopenia, growth retardation and skele
tal involvement. We analyzed data on genotype and key clinical paramet
ers in 35 Japanese patients with Gaucher disease type 1. Our data demo
nstrated that over 60% of patients had onset of Gaucher disease signs/
symptoms at less than 5 years. Sixty percent and 46% of evaluable pati
ents were splenectomized and developed severe bone involvement, respec
tively. Within mean follow-up periods of 8 years and 4 months, mean re
lative height and weight, severity score index and platelet count all
worsened to a highly significant degree. These data suggest that type
1 Gaucher disease tends to be severe and progressive in Japanese patie
nts, most of whom would be suitable for treatment and might indeed req
uire earlier and more aggressive therapy.